what is the difference between metformin and semaglutide maintenance of long-term weight loss after withdrawal in obese women with PCOS treated with metformin: a 2-year observational study Wegovy vs. metformin: Differences, similarities

el Wegovy acta sobre los receptores GLP-1 de las clulas Beta del pncreas, con una doble accin: Durante los periodos de niveles de azcar altos en sangre (despus de las comidas), estimula la secrecin de insulina, disminuyendo a su vez el glucagn

101 VellasB

BPC 157, also known as body protection compound 157, has a precise molecular structure that defines its research utility

The medication begins working within days after injection, with peak plasma concentrations typically reached within one to three days

Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls